Delivery Order SPE2DB22D3301-SPE2DB25FY8SA
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Loestrin 21 1-20 Tablet in quantities of 21 tablets, with a contract ceiling value of $2,983.50 and a firm fixed price structure. The contract is non-set-aside and represents a competitive award for pharmaceutical supply. This delivery order is completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $2,852.46 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply LOESTRIN 21 1-20 TABLET 21S to the agency. The contract has a completion date of February 20, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a...
- The Defense Logistics Agency awarded a delivery order valued at $14,675.22 to AmerisourceBergen Drug Corp for the supply of Loestrin FE 1-20 tablets in 28-count packages. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of July 30, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1.81K to AmerisourceBergen Drug Corp for LOESTRIN 21 1-20 tablets (21-count packages) on August 5, 2025, with completion targeted for August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in 28-count packaging, with a ceiling value of $2,225.65. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $2,174.60 firm fixed-price contract is for the supply of Loestrin 21 1.5-30 tablets, a prescription oral contraceptive. The order has an ultimate completion date of August 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $6,208.22 to AmerisourceBergen Drug Corp for Loestrin FE 1-20 tablets on July 30, 2025, with performance completion by July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be supplied to support federal medical procurement needs, with performance occurring at the contractor's facility in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Loestrin 21 1-20 tablet 21s, a pharmaceutical product. The contract has a ceiling value of $5,604.02 and a period of performance through April 9, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,597.79 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lo Loestrin FE 1-10 Tablet 28-count packages. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a discrete transaction within the...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8SADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,336.32 to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-tablet supply) on July 31, 2025, with ultimate completion by August 1, 2025. This is a firm fixed price, non-set-aside delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, brand-name and generic medications, and specialized medical commodities across multiple therapeutic domains. The contract supports federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 7/31/25 |